4D Molecular Therapeutics, Inc.

Ownership Transactions Reported by 19 Insiders

Symbol
FDMT on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
5858 Horton Street #455, Emeryville, CA

Insiders trading volume in the past year

4D Molecular Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Ra Capital Management, L.P. 10%+ Owner $83.3M Nov 13, 2024
Viking Global Investors Lp 10%+ Owner $78.2M -$10.5M -11.9% Jan 4, 2024
David Kirn Chief Executive Officer, Director $23.8M -$5.15M -17.8% Jul 10, 2024
David Schaffer Director $16.6M Oct 20, 2021
Bvf Partners L P/Il Other* $1.44M Nov 8, 2024
August J. Moretti Chief Financial Officer $203K May 15, 2023
Scott Bizily Chief Legal Officer $111K -$1.13M -91.1% Sep 16, 2024
Robert Kim Chief Medical Officer $29.4K -$738K -96.2% Feb 7, 2024
Carolyne Zimmermann Chief Business Officer Feb 1, 2022
John F. Milligan Director May 21, 2024
Fariborz Kamal President and COO Dec 11, 2023
Charles Theuer Director May 21, 2024
Nancy Miller-Rich Director May 21, 2024
Susannah Gray Director May 21, 2024
Shawn Tomasello Director May 21, 2024
Jacob Chacko Director May 21, 2024
Noriyuki Kasahara Director May 23, 2023
Uneek Mehra Chief Financial & Business Officer Dec 11, 2023
Robert Fishman Chief Medical Officer Sep 1, 2022

Recent Insider Transactions by Companies or Individuals for 4D Molecular Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.